Pharmaceuticals, Biotechnology and Life Sciences
– Takeda to Highlight Five Poster Presentations and an Oral Pipeline Symposium, Emphasizing a New Approach to Understanding Myelodysplastic Syndromes…
DUBLIN–(BUSINESS WIRE)–The “Global Microbots Drug Delivery Advances, Therapeutic Applications & Opportunity Insight 2025” report has been added to ResearchAndMarkets.com’s offering.…
LONDON–(BUSINESS WIRE)–Engitix Ltd, a company pioneering the development of both tissue-specific and disease-specific human extracellular matrix (ECM) for accelerating and…
PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, announces…
CHENGDU, China–(BUSINESS WIRE)–Clover Biopharmaceuticals, a biotechnology company focused on developing novel and transformative biologic therapies, today announced it has received…
Zuman to offer price discounts to CLSA Members generally and to those joining the CLSA Benefits Advantage Trust PLEASANTON, Calif.…
Expands Worldwide Clinical Trials’ Oncology Franchise MORRISVILLE, N.C.–(BUSINESS WIRE)–Worldwide Clinical Trials, Inc., (Worldwide) an award-winning, full-service, midsize, global CRO, announced…
SY-1365 Currently in Phase 1 Clinical Trial in Relapsed and Treatment-Resistant Ovarian and Breast Cancer Patients CAMBRIDGE, Mass.–(BUSINESS WIRE)–Syros Pharmaceuticals…
Trials to Evaluate the Safety, Tolerability and Preliminary Activity of Sensei’s SNS-301, in Combination with IMFINZI® (durvalumab), in Multiple Solid…
Promotion Reflects Vollmer’s Expanding Leadership Role with Company Since its 2014 Founding McKINNEY, Texas–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/soleohealthnamesCraigVollmerchiefcommericalofficer?src=hash" target="_blank"gt;#soleohealthnamesCraigVollmerchiefcommericalofficerlt;/agt;–Soleo Health, an innovative…